The FoxO transcription factors and metabolic regulation

FEBS Letters

Volumn 582, Issue 1, 2008, Pages 54-67

  Nakae, Jun ^a   Oki, Miyo ^a   Cao, Yongheng ^a  

^a 21st Century COE Program for Signal Transduction Disease: Diabetes Mellitus as Model   (Japan)

Author keywords

FoxO; Insulin resistance; Metabolism; Phosphorylation; Transcription; Type 2 diabetes

Indexed keywords

FOXO4 PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; INSULIN; NUCLEIC ACID BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; S6 KINASE; SIRTUIN 1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

ACETYLATION; ADIPOSE TISSUE; DEACETYLATION; ENDOTHELIUM CELL; FEEDBACK SYSTEM; GLUCOSE METABOLISM; HUMAN; HYPOTHALAMUS; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER METABOLISM; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; UBIQUITINATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; INSULIN; METABOLISM; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 37349100520     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.11.025     Document Type: Short Survey

References (133)

1. Klass M., and Hirsh D. Non-ageing developmental variant of Caenorhabditis elegans. Nature 260 (1976) 523-525
2. Riddle D.L., Swanson M.M., and Albert P.S. Interacting genes in nematode dauer larva formation. Nature 290 (1981) 668-671
3. Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum H.A., and Ruvkun G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389 (1997) 994-999
4. Lin K., Dorman J.B., Rodan A., and Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278 (1997) 1319-1322
5. Accili D., and Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117 (2004) 421-426
6. Greer E.L., and Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24 (2005) 7410-7425
7. Clark K.L., Halay E.D., Lai E., and Burley S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364 (1993) 412-420
8. Kaestner K.H., Knochel W., and Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14 (2000) 142-146
9. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
10. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
11. Kops G.J., and Burgering B.M. Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J. Mol. Med. 77 (1999) 656-665
12. Nakae J., Park B.C., and Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem. 274 (1999) 15982-15985
13. Rena G., Guo S., Cichy S.C., Unterman T.G., and Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J. Biol. Chem. 274 (1999) 17179-17183
14. Tang E.D., Nunez G., Barr F.G., and Guan K.L. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274 (1999) 16741-16746
15. Biggs III W.H., Meisenhelder J., Hunter T., Cavenee W.K., and Arden K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 96 (1999) 7421-7426
16. Brunet A., Kanai F., Stehn J., Xu J., Sarbassova D., Frangioni J.V., Dalal S.N., DeCaprio J.A., Greenberg M.E., and Yaffe M.B. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J. Cell Biol. 156 (2002) 817-828
17. Cahill C.M., Tzivion G., Nasrin N., Ogg S., Dore J., Ruvkun G., and Alexander-Bridges M. Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways. J. Biol. Chem. 276 (2001) 13402-13410
18. Brownawell A.M., Kops G.J., Macara I.G., and Burgering B.M. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol. Cell Biol. 21 (2001) 3534-3546
19. Rena G., Prescott A.R., Guo S., Cohen P., and Unterman T.G. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targeting. Biochem. J. 354 (2001) 605-612
20. Jacobs F.M., van der Heide L.P., Wijchers P.J., Burbach J.P., Hoekman M.F., and Smidt M.P. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 278 (2003) 35959-35967
21. Lin K., Hsin H., Libina N., and Kenyon C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat. Genet. 28 (2001) 139-145
22. Rena G., Bain J., Elliott M., and Cohen P. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 5 (2004) 60-65
23. Woods Y.L., Rena G., Morrice N., Barthel A., Becker W., Guo S., Unterman T.G., and Cohen P. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 355 (2001) 597-607
24. Oh S.W., Mukhopadhyay A., Svrzikapa N., Jiang F., Davis R.J., and Tissenbaum H.A. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc. Natl. Acad. Sci. USA 102 (2005) 4494-4499
25. Wang M.C., Bohmann D., and Jasper H. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121 (2005) 115-125
26. Essers M.A., Weijzen S., de Vries-Smits A.M., Saarloos I., de Ruiter N.D., Bos J.L., and Burgering B.M. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23 (2004) 4802-4812
27. Eisenmann D.M., Maloof J.N., Simske J.S., Kenyon C., and Kim S.K. The beta-catenin homolog BAR-1 and LET-60 Ras coordinately regulate the Hox gene lin-39 during Caenorhabditis elegans vulval development. Development 125 (1998) 3667-3680
28. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
29. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
30. Essers M.A., de Vries-Smits L.M., Barker N., Polderman P.E., Burgering B.M., and Korswagen H.C. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308 (2005) 1181-1184
31. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
32. Tseng Y.H., Butte A.J., Kokkotou E., Yechoor V.K., Taniguchi C.M., Kriauciunas K.M., Cypess A.M., Niinobe M., Yoshikawa K., Patti M.E., and Kahn C.R. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 7 (2005) 601-611
33. Nakae J., Kitamura T., Kitamura Y., Biggs III W.H., Arden K.C., and Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4 (2003) 119-129
34. Koubova J., and Guarente L. How does calorie restriction work?. Genes Dev. 17 (2003) 313-321
35. Imai S., Armstrong C.M., Kaeberlein M., and Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403 (2000) 795-800
36. Smith J.S., Brachmann C.B., Celic I., Kenna M.A., Muhammad S., Starai V.J., Avalos J.L., Escalante-Semerena J.C., Grubmeyer C., Wolberger C., and Boeke J.D. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl. Acad. Sci. USA 97 (2000) 6658-6663
37. Tissenbaum H.A., and Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410 (2001) 227-230
38. Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., Leid M., McBurney M.W., and Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429 (2004) 771-776
39. Bordone L., Motta M.C., Picard F., Robinson A., Jhala U.S., Apfeld J., McDonagh T., Lemieux M., McBurney M., Szilvasi A., Easlon E.J., Lin S.J., and Guarente L. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4 (2006) e31
40. Moynihan K.A., Grimm A.A., Plueger M.M., Bernal-Mizrachi E., Ford E., Cras-Meneur C., Permutt M.A., and Imai S. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2 (2005) 105-117
41. Kitamura Y.I., Kitamura T., Kruse J.P., Raum J.C., Stein R., Gu W., and Accili D. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2 (2005) 153-163
42. Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., and Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434 (2005) 113-118
43. Frescas D., Valenti L., and Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 280 (2005) 20589-20595
44. Nasrin N., Ogg S., Cahill C.M., Biggs W., Nui S., Dore J., Calvo D., Shi Y., Ruvkun G., and Alexander-Bridges M.C. DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc. Natl. Acad. Sci. USA 97 (2000) 10412-10417
45. Fukuoka M., Daitoku H., Hatta M., Matsuzaki H., Umemura S., and Fukamizu A. Negative regulation of forkhead transcription factor AFX (Foxo4) by CBP-induced acetylation. Int. J. Mol. Med. 12 (2003) 503-508
46. van der Horst A., Tertoolen L.G., de Vries-Smits L.M., Frye R.A., Medema R.H., and Burgering B.M. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J. Biol. Chem. 279 (2004) 28873-28879
47. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., Hu L.S., Cheng H.L., Jedrychowski M.P., Gygi S.P., Sinclair D.A., Alt F.W., and Greenberg M.E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004) 2011-2015
48. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., and Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 (2004) 551-563
49. Daitoku H., Hatta M., Matsuzaki H., Aratani S., Ohshima T., Miyagishi M., Nakajima T., and Fukamizu A. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc. Natl. Acad. Sci. USA 101 (2004) 10042-10047
50. Matsuzaki H., Daitoku H., Hatta M., Aoyama H., Yoshimochi K., and Fukamizu A. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc. Natl. Acad. Sci. USA 102 (2005) 11278-11283
51. Nakae J., Cao Y., Daitoku H., Fukamizu A., Ogawa W., Yano Y., and Hayashi Y. The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J. Clin. Invest. 116 (2006) 2473-2483
52. Matsuzaki H., Daitoku H., Hatta M., Tanaka K., and Fukamizu A. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. USA 100 (2003) 11285-11290
53. Aoki M., Jiang H., and Vogt P.K. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc. Natl. Acad. Sci. USA 101 (2004) 13613-13617
54. Carrano A.C., Eytan E., Hershko A., and Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1 (1999) 193-199
55. Tedesco D., Lukas J., and Reed S.I. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 16 (2002) 2946-2957
56. Kamura T., Hara T., Kotoshiba S., Yada M., Ishida N., Imaki H., Hatakeyama S., Nakayama K., and Nakayama K.I. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl. Acad. Sci. USA 100 (2003) 10231-10236
57. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., and Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86 (1996) 263-274
58. Huang H., Regan K.M., Wang F., Wang D., Smith D.I., van Deursen J.M., and Tindall D.J. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. USA 102 (2005) 1649-1654
59. Sakai T., Sakaue H., Nakamura T., Okada M., Matsuki Y., Watanabe E., Hiramatsu R., Nakayama K., Nakayama K.I., and Kasuga M. Skp2 controls adipocyte proliferation during the development of obesity. J. Biol. Chem. 282 (2007) 2038-2046
60. Hosaka T., Biggs III W.H., Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., and Arden K.C. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 101 (2004) 2975-2980
61. Furuyama T., Kitayama K., Shimoda Y., Ogawa M., Sone K., Yoshida-Araki K., Hisatsune H., Nishikawa S., Nakayama K., Ikeda K., Motoyama N., and Mori N. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279 (2004) 34741-34749
62. Castrillon D.H., Miao L., Kollipara R., Horner J.W., and DePinho R.A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301 (2003) 215-218
63. Paik J.H., Kollipara R., Chu G., Ji H., Xiao Y., Ding Z., Miao L., Tothova Z., Horner J.W., Carrasco D.R., Jiang S., Gilliland D.G., Chin L., Wong W.H., Castrillon D.H., and Depinho R.A. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128 (2007) 309-323
64. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., McDowell E.P., Lazo-Kallanian S., Williams I.R., Sears C., Armstrong S.A., Passegue E., Depinho R.A., and Gilliland D.G. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128 (2007) 325-339
65. O'Brien R.M., and Granner D.K. Regulation of gene expression by insulin. Physiol. Rev. 76 (1996) 1109-1161
66. O'Brien R M., Streeper R.S., Ayala J.E., Stadelmaier B.T., and Hornbuckle L.A. Insulin-regulated gene expression. Biochem. Soc. Trans. 29 (2001) 552-558
67. Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., and Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32 (2002) 245-253
68. Quinn P.G., and Yeagley D. Insulin regulation of PEPCK gene expression: a model for rapid and reversible modulation. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5 (2005) 423-437
69. Nakae J., Kitamura T., Silver D.L., and Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108 (2001) 1359-1367
70. Altomonte J., Richter A., Harbaran S., Suriawinata J., Nakae J., Thung S.N., Meseck M., Accili D., and Dong H. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E718-E728
71. Samuel V.T., Choi C.S., Phillips T.G., Romanelli A.J., Geisler J.G., Bhanot S., McKay R., Monia B., Shutter J.R., Lindberg R.A., Shulman G.I., and Veniant M.M. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55 (2006) 2042-2050
72. Matsumoto M., Pocai A., Rossetti L., Depinho R.A., and Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver. Cell Metab. 6 (2007) 208-216
73. Zhang W., Patil S., Chauhan B., Guo S., Powell D.R., Le J., Klotsas A., Matika R., Xiao X., Franks R., Heidenreich K.A., Sajan M.P., Farese R.V., Stolz D.B., Tso P., Koo S.H., Montminy M., and Unterman T.G. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281 (2006) 10105-10117
74. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., Rudolph D., Schutz G., Yoon C., Puigserver P., Spiegelman B., and Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 (2001) 179-183
75. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., Adelmant G., Stafford J., Kahn C.R., Granner D.K., Newgard C.B., and Spiegelman B.M. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 (2001) 131-138
76. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., and Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423 (2003) 550-555
77. Altomonte J., Cong L., Harbaran S., Richter A., Xu J., Meseck M., and Dong H.H. Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J. Clin. Invest. 114 (2004) 1493-1503
78. Matsumoto M., Han S., Kitamura T., and Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116 (2006) 2464-2472
79. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner-Weir S., and White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
80. Kubota N., Tobe K., Terauchi Y., Eto K., Yamauchi T., Suzuki R., Tsubamoto Y., Komeda K., Nakano R., Miki H., Satoh S., Sekihara H., Sciacchitano S., Lesniak M., Aizawa S., Nagai R., Kimura S., Akanuma Y., Taylor S.I., and Kadowaki T. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 49 (2000) 1880-1889
81. Kulkarni R.N., Bruning J.C., Winnay J.N., Postic C., Magnuson M.A., and Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 (1999) 329-339
82. Kulkarni R.N., Holzenberger M., Shih D.Q., Ozcan U., Stoffel M., Magnuson M.A., and Kahn C.R. Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet. 31 (2002) 111-115
83. Xuan S., Kitamura T., Nakae J., Politi K., Kido Y., Fisher P.E., Morroni M., Cinti S., White M.F., Herrera P.L., Accili D., and Efstratiadis A. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J. Clin. Invest. 110 (2002) 1011-1019
84. Hashimoto N., Kido Y., Uchida T., Asahara S., Shigeyama Y., Matsuda T., Takeda A., Tsuchihashi D., Nishizawa A., Ogawa W., Fujimoto Y., Okamura H., Arden K.C., Herrera P.L., Noda T., and Kasuga M. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat. Genet. 38 (2006) 589-593
85. Okamoto H., Hribal M.L., Lin H.V., Bennett W.R., Ward A., and Accili D. Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. J. Clin. Invest. 116 (2006) 775-782
86. Kitamura T., Nakae J., Kitamura Y., Kido Y., Biggs III W.H., Wright C.V., White M.F., Arden K.C., and Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Invest. 110 (2002) 1839-1847
87. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531-543
88. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
89. Rubin C.S., Lai E., and Rosen O.M. Acquisition of increased hormone sensitivity during in vitro adipocyte development. J. Biol. Chem. 252 (1977) 3554-3557
90. Accili D., and Taylor S.I. Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. Proc. Natl. Acad. Sci. USA 88 (1991) 4708-4712
91. Cinti S., Eberbach S., Castellucci M., and Accili D. Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis. Diabetologia 41 (1998) 171-177
92. Miki H., Yamauchi T., Suzuki R., Komeda K., Tsuchida A., Kubota N., Terauchi Y., Kamon J., Kaburagi Y., Matsui J., Akanuma Y., Nagai R., Kimura S., Tobe K., and Kadowaki T. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol. Cell Biol. 21 (2001) 2521-2532
93. Dowell P., Otto T.C., Adi S., and Lane M.D. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. J. Biol. Chem. 278 (2003) 45485-45491
94. Armoni M., Harel C., Karni S., Chen H., Bar-Yoseph F., Ver M.R., Quon M.J., and Karnieli E. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J. Biol. Chem. 281 (2006) 19881-19891
95. Bluher M., Michael M.D., Peroni O.D., Ueki K., Carter N., Kahn B.B., and Kahn C.R. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3 (2002) 25-38
96. Gelling R.W., Morton G.J., Morrison C.D., Niswender K.D., Myers Jr. M.G., Rhodes C.J., and Schwartz M.W. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab. 3 (2006) 67-73
97. Obici S., Feng Z., Karkanias G., Baskin D.G., and Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5 (2002) 566-572
98. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., and Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science 289 (2000) 2122-2125
99. Okamoto H., Obici S., Accili D., and Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J. Clin. Invest. 115 (2005) 1314-1322
100. Burks D.J., Font de Mora J., Schubert M., Withers D.J., Myers M.G., Towery H.H., Altamuro S.L., Flint C.L., and White M.F. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407 (2000) 377-382
101. Suzuki R., Tobe K., Aoyama M., Inoue A., Sakamoto K., Yamauchi T., Kamon J., Kubota N., Terauchi Y., Yoshimatsu H., Matsuhisa M., Nagasaka S., Ogata H., Tokuyama K., Nagai R., and Kadowaki T. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J. Biol. Chem. 279 (2004) 25039-25049
102. Lin X., Taguchi A., Park S., Kushner J.A., Li F., Li Y., and White M.F. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J. Clin. Invest. 114 (2004) 908-916
103. Kubota N., Terauchi Y., Tobe K., Yano W., Suzuki R., Ueki K., Takamoto I., Satoh H., Maki T., Kubota T., Moroi M., Okada-Iwabu M., Ezaki O., Nagai R., Ueta Y., Kadowaki T., and Noda T. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J. Clin. Invest. 114 (2004) 917-927
104. Choudhury A.I., Heffron H., Smith M.A., Al-Qassab H., Xu A.W., Selman C., Simmgen M., Clements M., Claret M., Maccoll G., Bedford D.C., Hisadome K., Diakonov I., Moosajee V., Bell J.D., Speakman J.R., Batterham R.L., Barsh G.S., Ashford M.L., and Withers D.J. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J. Clin. Invest. 115 (2005) 940-950
105. Xu A.W., Kaelin C.B., Takeda K., Akira S., Schwartz M.W., and Barsh G.S. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 115 (2005) 951-958
106. Kitamura T., Feng Y., Kitamura Y.I., Chua Jr. S.C., Xu A.W., Barsh G.S., Rossetti L., and Accili D. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 12 (2006) 534-540
107. Kim M.S., Pak Y.K., Jang P.G., Namkoong C., Choi Y.S., Won J.C., Kim K.S., Kim S.W., Kim H.S., Park J.Y., Kim Y.B., and Lee K.U. Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat. Neurosci. 9 (2006) 901-906
108. Furuyama T., Kitayama K., Yamashita H., and Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem. J. 375 (2003) 365-371
109. Tureckova J., Wilson E.M., Cappalonga J.L., and Rotwein P. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276 (2001) 39264-39270
110. Liu J.P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75 (1993) 59-72
111. Coleman M.E., DeMayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., and Schwartz R.J. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J. Biol. Chem. 270 (1995) 12109-12116
112. Hribal M.L., Nakae J., Kitamura T., Shutter J.R., and Accili D. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J. Cell Biol. 162 (2003) 535-541
113. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5 (2003) 87-90
114. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A., Lawrence J.C., Glass D.J., and Yancopoulos G.D. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3 (2001) 1014-1019
115. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., Pan Z.Q., Valenzuela D.M., DeChiara T.M., Stitt T.N., Yancopoulos G.D., and Glass D.J. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001) 1704-1708
116. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., and Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
117. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., Gonzalez M., Yancopoulos G.D., and Glass D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14 (2004) 395-403
118. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., Mochida K., Hata T., Matsuda J., Aburatani H., Nishino I., and Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279 (2004) 41114-41123
119. Jialal I., Crettaz M., Hachiya H.L., Kahn C.R., Moses A.C., Buzney S.M., and King G.L. Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues. Endocrinology 117 (1985) 1222-1229
120. Vicent D., Ilany J., Kondo T., Naruse K., Fisher S.J., Kisanuki Y.Y., Bursell S., Yanagisawa M., King G.L., and Kahn C.R. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest. 111 (2003) 1373-1380
121. Daly C., Wong V., Burova E., Wei Y., Zabski S., Griffiths J., Lai K.M., Lin H.C., Ioffe E., Yancopoulos G.D., and Rudge J.S. Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18 (2004) 1060-1071
122. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
123. Owens G.K., Kumar M.S., and Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84 (2004) 767-801
124. Miano J.M. Serum response factor: toggling between disparate programs of gene expression. J. Mol. Cell Cardiol. 35 (2003) 577-593
125. Wang D.Z., and Olson E.N. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr. Opin. Genet. Dev. 14 (2004) 558-566
126. Liu Z.P., Wang Z., Yanagisawa H., and Olson E.N. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 9 (2005) 261-270
127. Creemers E.E., Sutherland L.B., McAnally J., Richardson J.A., and Olson E.N. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133 (2006) 4245-4256
128. Puig O., Marr M.T., Ruhf M.L., and Tjian R. Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev. 17 (2003) 2006-2020
129. Ide T., Shimano H., Yahagi N., Matsuzaka T., Nakakuki M., Yamamoto T., Nakagawa Y., Takahashi A., Suzuki H., Sone H., Toyoshima H., Fukamizu A., and Yamada N. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 6 (2004) 351-357
130. Naimi M., Gautier N., Chaussade C., Valverde A.M., Accili D., and Van Obberghen E. Nuclear Foxo1 controls and integrates key signaling pathways in hepatocytes. Endocrinology (2007)
131. Luong N., Davies C.R., Wessells R.J., Graham S.M., King M.T., Veech R., Bodmer R., and Oldham S.M. Activated FOXO-mediated insulin resistance is blocked by reduction of TOR activity. Cell Metab. 4 (2006) 133-142
132. Teleman A.A., Chen Y.W., and Cohen S.M. Drosophila melted modulates FOXO and TOR activity. Dev. Cell 9 (2005) 271-281
133. Cao Y., Kamioka Y., Yokoi N., Kobayashi T., Hino O., Onodera M., Mochizuki N., and Nakae J. Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway. J. Biol. Chem. 281 (2006) 40242-40251